OTS - nal von minden plans to produce 80 million rapid corona tests per month
2020. November 20. 13:12
Moers, 20 November, 2020 (APA/OTS) - Rapid corona testing is
playing an increasingly important role in containing the pandemic
everywhere - even though the first vaccines are now in sight. The
medical technology company nal von minden GmbH from Moers, Germany,
is therefore doubling its production: 40 million rapid antigen
tests are already being produced in November. By January, this
figure is expected to rise to 80 million - every month!
"We are continuing to double our production of rapid corona
tests because we want to help contain the pandemic," says Roland
Meissner, Managing Director of nal von minden GmbH. The demand for
the NADAL® Covid-19 antigen test is very high. For this reason,
monthly production in November was already increased from 20
million rapid tests to 40 million. Now production capacity is being
further expanded - and fast. The new goal: to make 80 million rapid
corona tests available every month from January on. "Possibly
infected individuals can be detected immediately with the help of
the rapid tests and, thus, other people can be better protected
against corona," emphasises Meissner.
Even though the first vaccines are now in sight and new hope is
emerging that the pandemic will finally end, it will certainly take
some time until all or most people are vaccinated. "Rapid tests
continue to play a very important role, especially for the
protection of those in at risk groups," says Meissner. The rapid
tests are, therefore, primarily passed on to healthcare
professionals such as geriatric nurses or doctors.
The NADAL® Covid-19 antigen test is performed on site and does
not need to be sent to a laboratory. The result is available in
just 15 minutes. For the test, a swab from the mouth or nasopharynx
is taken by a medical professional. The antigen test detects
specific viral components directly: the so-called nucleoprotein
antigens. These proteins encapsulate the genetic material of
Covid-19 viruses, which consists of ribonucleic acid (RNA).
The quality of the NADAL® Covid-19 antigen test has been
repeatedly verified. Meissner: "The diagnostic specificity is over
99.9 percent, and the diagnostic sensitivity is 97.56 percent. The
specificity provides information on whether all healthy people
tested are recognised as being healthy. The sensitivity indicates
whether all sick people are recognised as being sick.
- Picture is available at AP Images (http://www.apimages.com) -
Press contact:
Hellwig PR
Gabriele Hellwig
+49 40 38 66 24 80
info@hellwig-pr.de
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók a
forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI által
szó szerint továbbított tartalomért minden esetben a beadó a
felelős.
© Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.